Recce Pharmaceuticals Ltd

ASX:RCE.AX

0.515 (AUD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q2
Revenue 02.3814.36503.08500.9970.640.051.07200.680.8620.4270.13900.040.1370.11400
Cost of Revenue 0.1730.1930.1420.0750.0790.1080.2050.0910.10.10.0290.3660.2380.2140.7030.3680.1760.0570.02800.083
Gross Profit -0.1732.1884.223-0.0753.006-0.1080.7920.549-0.050.971-0.0290.3130.6230.212-0.564-0.368-0.1360.080.0860-0.083
Gross Profit Ratio 00.9190.96700.97400.7940.858-1.0080.90600.4610.7230.498-4.0490-3.4080.5850.7550-3,961.667
Reseach & Development Expenses 04.7233.0854.0823.8062.4181.683.8771.2590.7260.0930.3230.1780.1940.6420.3570.14200.05400
General & Administrative Expenses 01.0190.9250.9250.3070.3070.4140.4140.2080.20800000000000
Selling & Marketing Expenses 08.3961.1188.2550.9944.6150.69610.4140.192.05200000000000
SG&A 12.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6820.8680.8550.7310.6740.7193.8840.3960.32200.087
Other Expenses 000000000000000000000
Operating Expenses 12.279.4147.9299.189.0414.9224.24110.8282.9462.2611.6821.3421.2761.2441.14410.7434.0320.35100.102
Operating Income -12.444-9.608-8.07-9.255-9.12-5.03-4.446-10.918-3.047-2.361-1.711-1.029-0.601-1.031-1.677-1.368-4.212-0.433-0.2650-0.185
Operating Income Ratio 0-4.034-1.8490-2.9560-4.458-17.059-60.932-2.2030-1.513-0.697-2.415-12.0410-105.378-3.158-2.3280-8,803.238
Total Other Income Expenses Net -0.381-0.135-0.0960.0330.0320.0470.1990.0860.062-0.042-0.013-0.037-0.029-0.013-0.0160.0353.327-3.523-00-0
Income Before Tax -12.825-9.743-8.166-9.223-9.088-4.984-4.247-10.832-2.985-2.404-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.2650-0.185
Income Before Tax Ratio 0-4.091-1.8710-2.9460-4.259-16.924-59.699-2.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.3290-8,811.333
Income Tax Expense -2.625-2.281-4.3110-3.085-0-0.926-0.64-0-1.07200000000000
Net Income -10.2-7.462-3.855-9.223-6.003-4.984-3.321-10.192-2.985-1.332-1.724-1.065-0.63-1.044-1.693-1.333-0.884-3.956-0.2650-0.185
Net Income Ratio 0-3.133-0.8830-1.9460-3.33-15.924-59.699-1.2430-1.567-0.731-2.446-12.1540-22.121-28.866-2.3290-8,811.333
EPS -0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.0060-0.009
EPS Diluted -0.05-0.042-0.021-0.052-0.034-0.037-0.019-0.076-0.022-0.011-0.017-0.012-0.007-0.013-0.022-0.018-0.012-0.096-0.0060-0.009
EBITDA -12.27-9.414-7.929-9.18-9.041-4.922-4.241-10.828-2.946-2.261-1.682-1.002-0.573-1.006-1.663-1.357-4.201-0.427-0.260-0.18
EBITDA Ratio 0-3.953-1.8160-2.9310-4.253-16.917-58.923-2.110-1.474-0.665-2.355-11.9370-105.121-3.114-2.2860-8,582.81